Pulse oximetry screening for detection of congenital heart defects at 1646 m in Albuquerque, New Mexico.

AIM: To determine the false-positive rate of pulse oximetry screening at moderate altitude, presumed to be elevated compared with sea level values and assess change in false-positive rate with time. METHODS: We retrospectively analysed 3548 infants in the newborn nursery in Albuquerque, New Mexico, (elevation 5400 ft) from July 2012 to October 2013. Universal pulse oximetry screening guidelines were employed after 24 hours of life but before discharge. Newborn babies between 36 and 36 6/7 weeks of gestation, weighing >2 kg and babies >37 weeks weighing >1.7 kg were included in the study. Log-binomial regression was used to assess change in the probability of false positives over time. RESULTS: Of the 3548 patients analysed, there was one true positive with a posteriorly-malaligned ventricular septal defect and an interrupted aortic arch. Of the 93 false positives, the mean pre- and post-ductal saturations were lower, 92 and 90%, respectively. The false-positive rate before April 2013 was 3.5% and after April 2013, decreased to 1.5%. There was a significant decrease in false-positive rate (p = 0.003, slope coefficient = -0.082, standard error of coefficient = 0.023) with the relative risk of a false positive decreasing at 0.92 (95% CI 0.88-0.97) per month. CONCLUSION: This is the first study in Albuquerque, New Mexico, reporting a high false-positive rate of 1.5% at moderate altitude at the end of the study in comparison to the false-positive rate of 0.035% at sea level. Implementation of the nationally recommended universal pulse oximetry screening was associated with a high false-positive rate in the initial period, thought to be from the combination of both learning curve and altitude. After the initial decline, it remained steadily elevated above sea level, indicating the dominant effect of moderate altitude.

Insulin regulation in AhR-null mice: embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR-null females.

The aryl hydrocarbon receptor (AhR) was originally characterized because of its high affinity binding of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. However, studies using AhR-null mice have demonstrated the importance of this protein in normal physiology and development. Here we demonstrate that AhR-null embryos develop cardiac enlargement, and that this phenotype is dependent, at least in part, on the maternal genotype. Neonates born to AhR-null females had increased heart weights regardless of the neonatal genotype, an outcome also observed in gestational diabetes. The cardiac hypertrophy markers, beta-myosin heavy chain and atrial natriuretic factor, and the cardiac proliferative index were increased in AhR-null embryos, indicating that the cardiac enlargement is associated with myocyte hypertrophy and hyperplasia, which begin prior to birth. Importantly, two- to three-month-old pregnant and seven-month-old nonpregnant females, but not nonpregnant three-month-old AhR-null females had significantly decreased fasting plasma insulin levels and a reduced ability to respond to exogenous insulin compared to controls. Despite these alterations in insulin regulation and responsiveness, pregnant AhR females did not have abnormal glucose tolerance tests and did not develop hyperglycemia, classic characteristics of gestational diabetes. However, twenty-three percent of seven-month-old AhR-null females did have altered glucose tolerance tests, but did not show hyperglycemia or increased hemoglobin A1C concentration under normal feeding conditions. While the ultimate cause of the neonatal phenotype remains unclear, these studies establish that the AhR is required for normal insulin regulation in pregnant and older mice and for cardiac development in embryonic mice.

Cyclic variation of integrated ultrasound backscatter: normal and abnormal myocardial patterns in children.

Cyclic variation of integrated backscatter (CVIBS) is altered in adults with myocardial infarction, allograft rejection, and cardiomyopathy. Its utility in children has not been tested. We studied 99 normal subjects: 16 fetuses, 13 newborns, 47 children, and 23 teenagers. Fifteen children with cardiomyopathy (13 dilated and two infiltrative) were studied to define abnormal CVIBS. CVIBS was measured in the anterior septum and the left ventricular posterior wall from a two-dimensional ultrasound image with an acoustic densitometry software package. CVIBS was similar in the anterior septum (3.7 +/- 1.9 dB) and the posterior wall (4.1 +/- 2.4 dB) of all children after birth. CVIBS was significantly lower in the fetus (septum: 2.8 +/- 1.6 dB) and in children with cardiomyopathy (septum: 0.6 +/- 1.6 dB, dilated; -1.2 +/- 4.2 dB, infiltrative; p < 0.01). Four children, studied after recovery from cardiomyopathy, had diminished CVIBS despite the return of normal systolic function. The pattern and extent of CVIBS in children is similar to that of adults. CVIBS is diminished in children with cardiomyopathy.

Acoustic quantification: a new tool for diagnostic echocardiography.

Acoustic quantification, a new ultrasound technique, provides a more direct assessment of the health of the myocardium than conventional echocardiography. Through software enhancements, acoustic quantification can characterize the myocardium as viable or nonviable, automatically track the endocardium throughout the cardiac cycle, and show myocardial perfusion defects when used with contrast enhancement. Thus, this technique shows promise in linking perfusion, viability, and global function in adults and perhaps in children.

Spontaneous chylothorax in Noonan syndrome. Treatment with prednisone.

OBJECTIVE: To describe a case of spontaneous chylothorax in a child with Noonan syndrome successfully treated with prednisone. DESIGN: Case report. SETTING: A pediatric cardiology referral center for the Rocky Mountain region. PATIENT: An 18-month-old girl with Noonan's syndrome, pulmonary stenosis, and hypertrophic cardiomyopathy who presented with spontaneous chylothorax. INTERVENTIONS: The child's chylothorax did not respond to thoracic duct ligation, tetracycline pleurodesis, and pleurectomy during a 2-month period. A low-fat diet was helpful but did not eliminate the problem. Prednisone was started orally at 1 mg/kg per dose twice daily and slowly tapered during 3 months. The chylothorax did not recur during 8 months of follow-up. CONCLUSIONS: Prednisone may be useful in the treatment of chylothorax in Noonan syndrome. A controlled clinical trial would be helpful but would be difficult in such a rare complication of an uncommon syndrome.

Ultrasound myocardial tissue characterization by integrated backscatter in children treated with anthracyclines.

The objective of our study was to evaluate integrated backscatter (IBS) measurement, an ultrasound method of myocardial tissue characterization, in children receiving cardiotoxic anthracyclines for malignancy. Myocardial injury is known to diminish the normal cyclic variation of IBS (CVIBS) during the cardiac cycle. We used a cross-sectional, case-controlled study of children receiving anthracyclines and serial, prospective observation in a subgroup of children. The study took place in a university-affiliated, tertiary referral center for pediatric cardiology and oncology. Children undergoing routine echocardiograms before, during, and after anthracycline treatment participated in this study. Children evaluated in the cardiology clinic for innocent murmurs participated as controls. There was no intervention. CVIBS was measured using specialized echocardiographic software which quantitates the intensity of backscattered echoes returning from myocardial cells within a user-defined region of interest. Standard echocardiographic measures of left ventricular function were also made. The results indicated that abnormal CVIBS was prevalent during anthracycline treatment (17%) and at late follow-up (20%). In serial studies, CVIBS decreased in all children after anthracycline treatment. Anthracycline dose and time since last dose did not predict which children would have abnormalities of left ventricular function or of CVIBS. This report provides preliminary evidence that CVIBS may be a useful supplement to the noninvasive, echocardiographic assessment of the heart during anthracycline treatment in children.

Characterization and regulation of insulin receptors in rat brain.

An in vitro receptor binding assay, using filtration to separate bound from free [125I]insulin, was developed and used to characterize insulin receptors on membranes isolated from specific areas of rat brain. The kinetic and equilibrium binding properties of central receptors were similar to those of hepatic receptors. The binding profiles in all tissues were complex and were consistent with binding in multiple steps or to multiple sites. Similar binding properties were found among receptors in olfactory tubercle/bulb, cerebral cortex, hippocampus, striatum, hypothalamus, and cerebellum. High affinity [125I]insulin binding sites (KD = 3-11 nM) were distributed evenly between membranes isolated from P1 and P2 fractions of these brain areas, with the exception of the olfactory tubercle in which binding to P2 membranes was four-fold greater (Bmax = 150 fmol/mg protein). One difference between insulin receptors in brain and peripheral target tissues, however, was observed. Following exposure to 0.17 microM insulin for 3 h at 37 degrees C, the number of specific [125I]insulin binding sites on adipocytes decreased by 40%, while the number of binding sites on minces of cerebral cortex/olfactory tubercle remained constant. The results suggest that although the binding characteristics of central and peripheral insulin receptors are similar, these receptors do not appear to be regulated in the same manner.